|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9433
|
|
pubmed:dateCreated |
2004-8-10
|
|
pubmed:abstractText |
Mycophenolate mofetil has replaced azathioprine in immunosuppression regimens worldwide to prevent graft rejection. However, evidence that its antirejection activity is better than that of azathioprine has been provided only by registration trials with an old formulation of ciclosporin and steroid. We aimed to compare the antirejection activity of these two drugs with a new formulation of ciclosporin.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:BosmansJean-LouisJL,
pubmed-author:DimitrovBorislav DBD,
pubmed-author:EOO,
pubmed-author:Ene-IordacheBogdanB,
pubmed-author:FedericoStefanoS,
pubmed-author:GanevaMariaM,
pubmed-author:GherardiGiuliaG,
pubmed-author:GottiElianaE,
pubmed-author:LestiMariadomenicaM,
pubmed-author:MouradGeorgesG,
pubmed-author:PericoNorbertoN,
pubmed-author:RemuzziGiuseppeG,
pubmed-author:RigottiPaoloP,
pubmed-author:RuggenentiPieroP,
pubmed-author:SalvadoriMaurizioM,
pubmed-author:SandriniSilvioS,
pubmed-author:SegoloniGiuseppeG,
pubmed-author:SparacinoVitoV,
pubmed-author:ValenteUmbertoU
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
364
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
503-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15302193-Acute Disease,
pubmed-meshheading:15302193-Adolescent,
pubmed-meshheading:15302193-Adult,
pubmed-meshheading:15302193-Aged,
pubmed-meshheading:15302193-Azathioprine,
pubmed-meshheading:15302193-Cyclosporine,
pubmed-meshheading:15302193-Female,
pubmed-meshheading:15302193-Graft Rejection,
pubmed-meshheading:15302193-Humans,
pubmed-meshheading:15302193-Immunosuppressive Agents,
pubmed-meshheading:15302193-Kidney Transplantation,
pubmed-meshheading:15302193-Male,
pubmed-meshheading:15302193-Middle Aged,
pubmed-meshheading:15302193-Mycophenolic Acid
|
|
pubmed:articleTitle |
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
|
|
pubmed:affiliation |
Clinical Research Centre for Rare Diseases, Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
